Brand / product

VALRATE

Divalproex sodium · 500 MG

₨ Official source-observed price PKR 508.99 5x5ml

PKR 20.36 / mL

✓ Official DRAP price source observed · Source checked 2026-10-09

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 20.36/ mL

Price positionNear medianvs like-for-like peer median

Peer comparators1current-price listings

🔒

MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence

View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Divalproex sodium
Therapeutic area: CNS & mental health
Drug class: Antiepileptics
ATC: N03
Strength: 500 MG
Dosage form: Injection
Pack: 5x5ml
Registration no.: 031049
Price record verified: 2026-08-09
Latest DRAP source check: 2026-10-09 03:22

Manufacturer

AGP Limited

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Summary

About VALRATE 500 MG injection

VALRATE 500 MG injection contains Divalproex sodium 500 MG. It is registered with DRAP by AGP Limited (registration no. 031049). Its official price is PKR 508.99 for a pack of 5x5ml. This price has applied since 27 July 2026. It is sold in 2 pack sizes: 5x5ml and 10x5ml. VALRATE is also available as 250 mg tablet and 500 mg tablet. No other brand of Divalproex sodium 500 MG in this form is listed in Pakistan.

Pack sizes

VALRATE 500 MG pack sizes and prices

Pack	Official price	Per tablet
5x5ml (this page)	PKR 508.99	—
10x5ml	PKR 1,018.01	—

Same brand

Other strengths of VALRATE

VALRATE 250 mgTablet · 100's · PKR 847.74 VALRATE 500 mgTablet · 100's · PKR 1,323.73

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (5x5ml). Current price PKR 508.99, effective 27 Jul 2026.

Cite this price history

MedInfoBase. VALRATE 500 MG, 5x5ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/valrate-500-mg-031049-5x5ml-agp-limited/ (accessed 9 October 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 508.99	2026-07-27	2026-08-09	DRAP PharmaPrice Index	Current

Same generic

Other listed brands

DAPAKAN 500 mgPlatinum Pharmaceuticals · PKR 1,323.73 DAPAKAN 500 mgPlatinum Pharmaceuticals · PKR 270.22 DAPAKAN 250 mgPlatinum Pharmaceuticals · PKR 847.74 DAPAKAN 250 mgPlatinum Pharmaceuticals · PKR 254.32 Depilap 500 mgNeutro Pharma (Pvt.) Ltd., · PKR 1,323.73 Depilap 500 mgNeutro Pharma (Pvt.) Ltd., · PKR 269.84 Dipodium 250 mgAmarant Pharmaceuticals Private Limited · PKR 847.74 Dipodium DS 500 mgAmarant Pharmaceuticals Private Limited · PKR 1,323.73

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 031049

MedInfoBase. (2026). VALRATE 500 MG Injection (5x5ml), AGP Limited — registration and price record [Data set]. MedInfoBase. Retrieved October 9, 2026, from https://medinfobase.com/brand/valrate-500-mg-031049-5x5ml-agp-limited/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 031049.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.